Oxford Finance LLC

Oxford Finance delivers flexible financial solutions to healthcare and life sciences companies worldwide.

Business Model:

Revenue: $25M

Employees: 51-200

Rankings

Detailed Oxford Finance LLC Information

Geographic Data

Oxford Finance LLC headquarters map

Address: 115 South Union Street

City: Alexandria

State: VA

Zip: 22314

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$900M

Metrics

2,110,333Website Global Rank

9,425Website Monthly Traffic

Twitter Followers

Description

Oxford Finance LLC delivers flexible financial solutions to healthcare and life sciences companies worldwide. Our capital provides clients with the fuel needed for innovation and growth.

Contact Phone:
+17035194900

Contact Email:

Announced Date Company Transaction Money Raised
9/2014 Asensus Surgical Post-IPO Debt 25M
8/2015 Ocera Therapeutics Post-IPO Debt 20M
7/2014 Cerus Post-IPO Debt 30M
11/2015 Continuum Healthcare Debt Financing 13.9M
3/2011 NeoVista Debt Financing 20M
10/2019 Equillium Post-IPO Debt 20M
9/2020 Vedanta Biosciences Debt Financing 15M
10/2013 Monteris Medical Debt Financing 5M
12/2020 RxSight Debt Financing 60M
10/2012 Entellus Medical Debt Financing 17M
8/2014 diaDexus Post-IPO Debt 15M
9/2020 Selecta Biosciences Post-IPO Debt 35M
6/2022 Antheia Debt Financing 0
12/2013 Apollo Endosurgery Debt Financing 50M
7/2015 AlterG Debt Financing 15M
7/2010 Tethys BioScience Debt Financing 10M
6/2012 Avanir Pharmaceuticals Post-IPO Debt 30M
11/2015 Zyga Technology Debt Financing 15M
11/2022 Pearl Street Debt Financing 115M
8/2013 PrimeSource Healthcare Systems Debt Financing 5.5M
10/2013 Monteris Medical Venture Round 0
10/2022 ALX Oncology Post-IPO Debt 100M
1/2017 Eiger BioPharmaceuticals Post-IPO Debt 25M
7/2021 4D Pharma Post-IPO Debt 29.9M
3/2016 Superior Biologics Debt Financing 50M
6/2016 Regulus Therapeutics Post-IPO Debt 30M
12/2013 Amicus Therapeutics Post-IPO Debt 10M
3/2019 Evolus Post-IPO Debt 100M
4/2014 Larimar Therapeutics Debt Financing 20M
2/2020 Syros Pharmaceuticals Debt Financing 60M
2/2019 Continuing Healthcare Solutions Debt Financing 43.3M
4/2017 Cerapedics Debt Financing 20M
5/2017 Castle Biosciences Debt Financing 20M
6/2019 AcelRx Pharmaceuticals Post-IPO Debt 25M
1/2015 Minerva Neuroscience Post-IPO Debt 15M
1/2022 Choice Health at Home Debt Financing 0
5/2013 CardioFocus Debt Financing 11M
7/2010 Zogenix Debt Financing 35M
11/2017 Puma Biotechnology Post-IPO Equity 100M
5/2016 ADMA Biologics Post-IPO Debt 4M
8/2017 AirXpanders Post-IPO Debt 15M
10/2020 SpendMend Debt Financing 55M
12/2020 Nature’s Fynd Debt Financing 45M
6/2015 ADMA Biologics Post-IPO Debt 21M
4/2007 Argos Therapeutics Debt Financing 5M
9/2019 Codex DNA Series A 25M
7/2016 Senseonics Post-IPO Debt 30M
11/2017 VitalConnect Debt Financing 20M
2/2012 Horizon Pharma Post-IPO Debt 60M
4/2015 Celula Debt Financing 10M
9/2013 Singulex, Inc. Debt Financing 40M
7/2021 Impel NeuroPharma Debt Financing 50M
2/2022 Centogene Post-IPO Debt 0
1/2017 ConforMIS Post-IPO Debt 50M
2/2011 Intuity Medical Venture Round 20M
3/2020 Epic Healthcare Staffing Debt Financing 104.3M
11/2021 Viracta Therapeutics Post-IPO Debt 0
5/2021 Kala Pharmaceuticals Post-IPO Debt 125M
9/2020 Enable Injections Debt Financing 25M
8/2019 MolecuLight Debt Financing 7.5M
4/2014 Conventus Orthopaedics Debt Financing 10M
12/2013 CymaBay Therapeutics Debt Financing 5M
4/2017 Reata Pharmaceuticals Post-IPO Debt 35M
9/2010 SuperDimension Debt 15M
7/2014 Cardiff Oncology Post-IPO Debt 15M
6/2014 Tobira Therapeutics Debt Financing 15M
3/2018 Xeris Pharmaceuticals Debt Financing 45M
3/2011 AirXpanders Series C 3M
11/2021 Platelet BioGenesis Series B 75.5M
10/2007 Tengion Series C 33M
3/2022 Verastem Oncology Post-IPO Debt 0
10/2022 Verona Pharma Post-IPO Debt 150M
5/2012 Pacira Pharmaceuticals Post-IPO Debt 27.5M
1/2014 Auspex Pharmaceuticals Debt Financing 15M
8/2016 CVRx Debt Financing 20M
9/2014 Trevena Post-IPO Debt 35M
12/2015 Aratana Therapeutics Post-IPO Debt 40M
8/2014 Tarsa Therapeutics Debt Financing 10M
5/2014 Ceterix Orthopaedics Debt Financing -
10/2009 Zogenix Series B 36M
9/2014 Pulmonx Debt Financing 20M
5/2015 Edgemont Pharmaceuticals Debt Financing 5M
9/2020 Collage Rehabilitation Partners Debt Financing -
9/2019 Xeris Pharmaceuticals Post-IPO Debt 85M
4/2019 Summit Healthcare REIT Debt Financing 96M
10/2019 LogicBio Therapeutics Post-IPO Debt 20M
9/2012 CareDx Debt Financing 15M
5/2022 Silk Road Medical Post-IPO Debt 250M
8/2016 Bi02 Medical Debt Financing 3M
1/2017 Oxford BioTherapeutics Debt Financing 10M
2/2012 Ceptaris Therapeutics Debt Financing 15M
8/2014 HTG Molecular Diagnostics Debt Financing 16M
1/2015 InterValve Debt Financing 3M
8/2011 Keystone Dental Debt Financing 20M
8/2019 ObsEva Post-IPO Debt 75M
12/2016 Strongbridge Biopharma Post-IPO Debt 40M
3/2014 Omeros Post-IPO Debt 32M
6/2014 Intellicyt Debt Financing 4M
11/2022 Renibus Therapeutics Debt Financing 10M
5/2016 Omeros Post-IPO Debt 20M
1/2016 Omeros Post-IPO Debt 70M
1/2021 Immunocore Debt Financing 100M
9/2007 CASI Pharmaceuticals Post-IPO Debt 20M
12/2016 Veran Medical Technologies Venture Round 31M
5/2015 Labcyte Debt Financing 17M
11/2015 Venus Concept Debt Financing 20M
6/2016 Monteris Medical Debt Financing 10M
6/2014 Durect Post-IPO Equity 20M
1/2016 Bi02 Medical Debt Financing 5M
2/2020 Genapsys Debt Financing 75M
4/2015 Inhibrx Debt Financing 20M
4/2012 NanoString Technologies Debt Financing 15M
4/2021 Mainstay Medical Debt 50M
11/2018 Nevakar Debt Financing 30M
7/2012 LENSAR, Inc. Debt Financing 10M
7/2013 Continuum Healthcare Debt Financing 11.5M
12/2013 Halozyme Therapeutics Post-IPO Debt 30M
4/2018 Cardiac Dimensions Series B 39M
4/2014 Senseonics Debt Financing 10M
1/2014 Halozyme Therapeutics Post-IPO Debt 20M
12/2020 Greenbrook TMS Post-IPO Debt 30M
11/2007 BioVex Series E 35M
11/2021 Kezar Life Sciences Post-IPO Debt 50M
3/2011 SynergEyes Venture Round 5M
6/2014 Relypsa Post-IPO Debt 35M
6/2022 SeLux Diagnostics Debt Financing 0
2/2009 Pearl Therapeutics Debt Financing 8M
12/2015 MDRejuvena Debt Financing 3M
12/2013 Acura Pharmaceuticals Post-IPO Debt 10M
11/2011 Avantis Medical Systems Debt Financing 3M
7/2010 Zogenix Venture Round 0
1/2022 Sierra Oncology Post-IPO Debt 125M
4/2016 Nuvectra Debt Financing 45M
6/2016 Ignyta Post-IPO Debt 42M
5/2019 RefleXion Medical Debt Financing 60M
10/2020 Scholar Rock Post-IPO Debt 50M
7/2018 QuVa Pharma Debt Financing 41M
3/2014 Navidea Biopharmaceuticals Post-IPO Debt 30M
11/2018 Karius Debt Financing 25M
11/2014 Lexicon Pharmaceuticals Equity 150M
4/2015 ReShape Lifesciences Post-IPO Debt 12M
7/2013 Plus Therapeutics Post-IPO Debt 27M
1/2019 AliveCor Debt Financing 20M
1/2013 Agile Therapeutics Debt Financing 15M
1/2014 Proteus Digital Health Debt Financing 31.6M
4/2014 RF Surgical Systems Venture Round 15M
6/2022 Antheia Debt Financing 0
6/2022 SeLux Diagnostics Debt Financing 0
5/2022 Silk Road Medical Post-IPO Debt 0
3/2022 Verastem Oncology Post-IPO Debt 0
3/2022 Lexicon Pharmaceuticals Post-IPO Debt 0
2/2022 Centogene Post-IPO Debt 0
1/2022 Sierra Oncology Post-IPO Debt 0
1/2022 Choice Health at Home Debt Financing 0
11/2021 Kezar Life Sciences Post-IPO Debt 0
11/2021 Viracta Therapeutics Post-IPO Debt 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research